- Home
- / Athira Pharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Athira Pharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0.5
2024-10-29
Market Capitalization
$18.9 M
2024-10-29
CreditSafe Score
?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|
| General and administrative expense | 6.7M | 21.2M | 32.6M | 33.3M | 26.1M | 16.7M |
| Operating expense total | 20.0M | 64.0M | 94.0M | 127.1M | 96.8M | 34.2M |
| EBIT | (20.0M) | (64.0M) | (104.0M) | (125.5M) | (100.9M) | (102.3M) |
| Interest income | 124.0K | 337.0K | ||||
| Interest expense | 367.0K | 3.0K | ||||
| Pre tax profit | (20.0M) | (55.0M) | (95.8M) | (117.4M) | (96.9M) | (105.6M) |
| Net Income | (20.0M) | (54.9M) | (95.6M) | (117.7M) | (96.9M) | (105.6M) |
| EPS | (2.5) | (3.1) | (2.5) | (24.7) |